Lantheus Holdings, Inc.
LNTHNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 23, 2026 close
- Market cap
- $6.74B
- P/E (TTM)
- 24.48
- Forward P/E
- 23.91
- Dividend yield
- -
- 52-week range
- $50.16$111.86
- Volume (live)
- -
- Avg. volume (3M)
- 1.06M
Lantheus Holdings (LNTH) Stock Price & Financial Analysis
Lantheus Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $99.80 - $100.09 |
|---|---|
| 52-Week High | $111.86 |
| 52-Week Low | $50.16 |
| Open | $99.97 |
| Volume (last close) | 877.04K |
| Average Volume (3M) | 1.06M |
| Revenue (TTM) | 1.56B |
|---|---|
| Net Income (TTM) | 275.31M |
| Free Cash Flow (TTM) | 387.83M |
| EPS (TTM) | $4.12 |
| Profit Margin | 17.69% |
| Operating Margin | 19.43% |
| Return on Equity (ROE) | 20.99% |
| Debt to Equity | 0.48 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 6.74B |
|---|---|
| Shares Outstanding | 67.52M |
| P/E Ratio (TTM) | 24.48 |
| Forward P/E | 23.91 |
| Price to Sales (P/S) | 4.33 |
| Price to Book (P/B) | 5.14 |
| EV/EBITDA | 14.59 |
| 50-Day MA | $100.34 |
|---|---|
| 200-Day MA | $90.09 |
| 1-Year Change | +77.12% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Lantheus Holdings at a Glance
As of the Oct 23, 2026 close, Lantheus Holdings (LNTH) has a market capitalization of $6.74B. The stock trades at 24.5× trailing earnings, 23.9× forward earnings and 4.3× sales. Over the trailing twelve months it earned $275.31M on revenue of $1.56B (a 17.7% profit margin) and generated $387.83M of free cash flow. Revenue grew 2.4% year over year.
As of its latest reported balance sheet, it holds $593.30M in cash and securities against $624.96M of debt, a net debt position of $31.66M.
Lantheus Holdings does not currently pay a dividend.
The share price is up 77.1% over the past year. At $99.80 (the Oct 23, 2026 close) it sits within its 52-week range of $50.16 to $111.86, above its 200-day moving average of $90.09.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $104.48, 4.7% above the Oct 23, 2026 close.
Frequently Asked Questions About Lantheus Holdings
What is the current stock price for LNTH?
As of the Oct 23, 2026 close, LNTH stock trades at $99.80. The 52-week range is $50.16–$111.86, with a day range of $99.80–$100.09.
What is the P/E ratio for LNTH?
As of the Oct 23, 2026 close, Lantheus Holdings's trailing twelve-month (TTM) P/E ratio is 24.5, meaning investors pay $24.5 for every $1 of annual earnings. The forward P/E is 23.9, reflecting analyst expectations for future earnings. Lantheus Holdings operates in the Healthcare sector.
Does LNTH pay dividends?
Lantheus Holdings does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for LNTH?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for LNTH is Hold. The average 12-month price target is $104.48, a 4.7% upside from the Oct 23, 2026 close of $99.80.
What is the market cap of LNTH?
As of the Oct 23, 2026 close, Lantheus Holdings's market capitalization is $6.74B, classifying it as a mid-cap company. Lantheus Holdings operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.